Found: 15
Select item for more details and to access through your institution.
Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 197, doi. 10.1038/bmt.2014.259
- By:
- Publication type:
- Article
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 7, p. 926, doi. 10.1038/bmt.2012.279
- By:
- Publication type:
- Article
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1051, doi. 10.1038/bmt.2011.217
- By:
- Publication type:
- Article
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 817, doi. 10.1038/bmt.2011.181
- By:
- Publication type:
- Article
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 810, doi. 10.1038/bmt.2011.194
- By:
- Publication type:
- Article
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 5, p. 700, doi. 10.1038/bmt.2011.158
- By:
- Publication type:
- Article
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 6, p. 847, doi. 10.1038/bmt.2010.203
- By:
- Publication type:
- Article
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3–6/6 HLA matched donors.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 4, p. 327, doi. 10.1038/bmt.2008.321
- By:
- Publication type:
- Article
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection.
- Published in:
- Bone Marrow Transplantation, 2008, v. 41, n. 1, p. 39, doi. 10.1038/sj.bmt.1705882
- By:
- Publication type:
- Article
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 113, doi. 10.1038/leu.2012.186
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 7, p. 1686, doi. 10.1038/leu.2012.1
- By:
- Publication type:
- Article
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 12, p. 2184, doi. 10.1038/leu.2008.241
- By:
- Publication type:
- Article